Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Nanobiotix
  6. News
  7. Summary
    NANO   FR0011341205

NANOBIOTIX

(NANO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about NANOBIOTIX
01/10NANOBIOTIX : Provides Corporate Update and Highlights Key 2022 Milestone Targets - Form 6-..
PU
01/10NANOBIOTIX Provides Corporate Update and Highlights Key 2022 Milestone Targets
BU
01/05Nanobiotix Enrolls First Patient In Late-Stage Trial For Head, Neck Cancer Treatment
MT
01/05Nanobiotix Enrolls First Patient in Phase 3 Study of Head, Neck Cancer Treatment
MT
01/05NANOBIOTIX : Announces First Patient Enrolled in NANORAY-312 Global Phase III Registration..
PU
01/05NANOBIOTIX Announces First Patient Enrolled in NANORAY-312 Global Phase III Registratio..
BU
01/05Nanobiotix S.A. Announces First Patient Enrolled in NANORAY-312 Global Phase III Regist..
CI
01/04Nanobiotix Announces Participation at Three Virtual Investor Conferences in January 202..
BU
2021NANOBIOTIX : Monthly statement on outstanding equity shares and voting rights
CO
2021NANOBIOTIX : Monthly statement on outstanding equity shares and voting rights
CO
2021NANOBIOTIX : to Present at the 4th Annual Evercore ISI HealthCONx Conference - Form 6-K
PU
2021NANOBIOTIX to Present at the 4th Annual Evercore ISI HealthCONx Conference
BU
2021Nanobiotix's Cancer Drug Shows Potential As Combination Therapy In Preclinical Study
MT
2021NANOBIOTIX Announces New Preclinical Data Highlighting NBTXR3 Immune Priming and Checkp..
PU
2021NANOBIOTIX Announces New Preclinical Data Highlighting NBTXR3 Immune Priming and Checkp..
BU
More most relevant news
All news about NANOBIOTIX
01/10NANOBIOTIX : Provides Corporate Update and Highlights Key 2022 Milestone Targets - Form 6-..
PU
01/10NANOBIOTIX Provides Corporate Update and Highlights Key 2022 Milestone Targets
BU
01/05Nanobiotix Enrolls First Patient In Late-Stage Trial For Head, Neck Cancer Treatment
MT
01/05Nanobiotix Enrolls First Patient in Phase 3 Study of Head, Neck Cancer Treatment
MT
01/05NANOBIOTIX : Announces First Patient Enrolled in NANORAY-312 Global Phase III Registration..
PU
01/05NANOBIOTIX Announces First Patient Enrolled in NANORAY-312 Global Phase III Registratio..
BU
01/05Nanobiotix S.A. Announces First Patient Enrolled in NANORAY-312 Global Phase III Regist..
CI
01/04Nanobiotix Announces Participation at Three Virtual Investor Conferences in January 202..
BU
2021NANOBIOTIX : Monthly statement on outstanding equity shares and voting rights
CO
2021NANOBIOTIX : Monthly statement on outstanding equity shares and voting rights
CO
More news
News in other languages on NANOBIOTIX
01/10NANOBIOTIX : le titre avance suite à un point d'activité
01/10Les valeurs à suivre aujourd'hui à la Bourse de Paris Lundi 10 janvier 2022
01/10Hausses de taux à gogo ?
01/10NANOBIOTIX : visibilité financière prolongée jusqu’au deuxième trimestre 2023
01/10EN DIRECT DES MARCHES : Veolia, Sodexo, Orange, Atos, CGG, Alcon, Idorsia, Telecom Italia...
01/10Nanobiotix actualise ses principaux objectifs et fait le point sur ses activités prévue..
01/07NANOBIOTIX : plus forte baisse du SRD à la clôture du vendredi 7 janvier 2022
01/07NANOBIOTIX : plus forte baisse du SRD à la mi-séance du vendredi 7 janvier 2022
01/06NANOBIOTIX : plus forte hausse du marché SRD à la clôture du jeudi 6 janvier 2022 -
01/06CAC40 : la lourdeur l'emporte, le Nasdaq préserve les 15.000
More news
Analyst Recommendations on NANOBIOTIX
2021NANOBIOTIX S A : Evercore ISI Starts Nanobiotix at Outperform
MT
More recommendations
Press releases
01/10NANOBIOTIX : Provides Corporate Update and Highlights Key 2022 Milestone Targets - Form 6-..
PU
01/10NANOBIOTIX Provides Corporate Update and Highlights Key 2022 Milestone Targets
BU
01/05NANOBIOTIX : Announces First Patient Enrolled in NANORAY-312 Global Phase III Registration..
PU
01/05NANOBIOTIX Announces First Patient Enrolled in NANORAY-312 Global Phase III Registratio..
BU
01/04Nanobiotix Announces Participation at Three Virtual Investor Conferences in January 202..
BU
More press releases
Upcoming event on NANOBIOTIX